ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
뎅기열 치료 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다.
예측 기간의 성장은 보편적 백신 개발, 백신 가용성 확대, 공공-민간 파트너십, 원격 의료의 성장, 그리고 더 나은 의료 관리를 위한 정책 프레임워크의 강화에 기인할 수 있습니다
예측 기간에 있어서의 주요한 동향으로서는 차세대 뎅기열 백신의 개발, 신약에 있어서의 인공지능(AI)의 이용, 스마트 콘택트 트레이싱 툴의 대두, 3D 프린팅 백신의 탐구, CRISPR 기술의 표적 바이러스 치료에의 이용 등을 들 수 있습니다.
뎅기열의 이환율 증가는 미래의 뎅기열 치료 시장의 성장을 가속할 것으로 예측됩니다.
뎅기열은 모기를 매개로 한 바이러스 감염으로, 독감과 유사한 증상을 유발하며 치료하지 않으면 심각한 합병증을 초래할 수 있습니다.
뎅기열 환자 증가는 도시화, 모기 번식을 조장하는 기후 변화, 불충분한 매개 모기 대책, 위험이 높은 지역의 인구 증가 등의 요인으로 인해 시기적절한 뎅기열 치료는 환자의 예후 개선과 공중 보건 의식의 향상을 통해 심각한 증상을 완화하고, 합병증을 예방하고, 질병의 만연을 억제함으로써 이환율을 저하시키는데 도움이 됩니다. 이 보고서에 따르면 아메리카 지역의 뎅기열 환자 수는 460만 명 이상으로 급증했으며, 약 4,000명이 사망했습니다.
뎅기열 치료 시장의 주요 기업은 치료 효과를 향상시키고 질병의 중증도를 줄이고 뎅기 바이러스의 여러 혈청형에 동시에 대처하기 위해 광역 항바이러스제물 등의 혁신에 주력하고 있습니다. Pharmaceutical Co.Ltd.는 COVID-19와 뎅기열을 포함한 여러 바이러스 감염을 치료하기 위해 고안된 혁신적인 광역 항바이러스제물인 XAFTY를 출시했습니다. 이를 특징으로 하며 임상시험에서 안전성과 효능이 입증된 것 외에도 다양한 RNA 바이러스를 표적으로 하고 공중위생상의 긴급사태에 직면하는 지역에서의 신속한 대응능력과 함께 미래에 발생할 수 있는 위협에 대한 범용성을 갖추고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 뎅기열 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 뎅기열 치료 시장 : 성장률 분석
세계의 뎅기열 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 뎅기열 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 뎅기열 치료 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 뎅기열 치료 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
백신
아세트아미노펜
세계의 뎅기열 치료 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
비경구
오랄
세계의 뎅기열 치료 시장 : 약제 클래스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
NSAIDs
항생제
코르티코스테로이드
세계의 뎅기열 치료 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 뎅기열 치료 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원
전문 클리닉
재택 헬스케어
세계의 뎅기열 치료 시장 : 백신유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
생약독화 백신
재조합 백신
불활성화 백신
세계의 뎅기열 치료 시장 : 아세트아미노펜유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
경구 아세트아미노펜
정맥내 아세트아미노펜
제7장 지역별/국가별 분석
세계의 뎅기열 치료 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 뎅기열 치료 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
뎅기열 치료 시장 : 경쟁 구도
뎅기열 치료 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Novartis International AG
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Boehringer Ingelheim GmbH
Hetero Labs Limited
Sun Pharmaceutical Industries Limited
Dr. Reddy's Laboratories Limited
Cipla Incorporated
Emergent BioSolutions Inc.
Bharat Biotech International Limited
Inovio Pharmaceuticals Inc.
Gennova Biopharmaceuticals Ltd.
ABIVAX SA
Cadila Healthcare Limited
Biological E. Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
뎅기열 치료 시장 2029 : 새로운 기회를 제공하는 국가
뎅기열 치료 시장 2029 : 새로운 기회를 제공하는 부문
뎅기열 치료 시장 2029 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Dengue treatment involves the medical management and supportive care for individuals infected with the dengue virus, which is transmitted by Aedes mosquitoes. The treatment primarily focuses on supportive care, such as managing fever with paracetamol, providing hydration through oral or intravenous fluids, and closely monitoring for complications such as bleeding or shock to ensure timely intervention and recovery.
The main types of dengue treatment include vaccines and acetaminophen. Vaccines are biological substances that trigger the body's immune system to provide immunity against specific diseases. These vaccines can be administered through various routes, including parenteral and oral. The key drug classes involved in dengue treatment include NSAIDs, antibiotics, and corticosteroids, which are distributed through different channels such as hospital pharmacies, retail pharmacies, and online pharmacies. These treatments are used by a range of end users, including hospitals, specialty clinics, and home healthcare settings.
The dengue treatment market research report is one of a series of new reports from The Business Research Company that provides dengue treatment market statistics, including dengue treatment industry global market size, regional shares, competitors with a dengue treatment market share, detailed dengue treatment market segments, market trends and opportunities, and any further data you may need to thrive in the dengue treatment industry. This dengue treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dengue treatment market size has grown rapidly in recent years. It will grow from $2.10 billion in 2024 to $2.35 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to several factors, including improvements in diagnostic tools, significant efforts by governments and non-governmental organizations (NGOs), the establishment of epidemiological surveillance systems, substantial investments in research and development (R&D), and community education initiatives aimed at raising awareness and preventing dengue.
The dengue treatment market size is expected to see rapid growth in the next few years. It will grow to $3.64 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to the development of universal vaccines, an expansion of vaccine availability, public-private partnerships, the growth of telemedicine, and the enhancement of policy frameworks for better healthcare management. Major trends in the forecast period include the development of next-generation dengue vaccines, the use of artificial intelligence (AI) in drug discovery, the rise of smart contact tracing tools, the exploration of 3D-printed vaccines, and the use of CRISPR technology for targeted virus treatments.
The increasing incidence of dengue is anticipated to drive the growth of the dengue treatment market in the future. Dengue is a mosquito-borne viral infection that causes flu-like symptoms and can lead to severe complications if left untreated. The rise in dengue cases is largely attributed to factors such as urbanization, climate change that favors mosquito breeding, insufficient vector control measures, and population growth in high-risk areas. Timely dengue treatment helps reduce the incidence rate by alleviating severe symptoms, preventing complications, and controlling the spread of the disease through improved patient outcomes and enhanced public health awareness. For example, in 2023, a report by the Centers for Disease Control and Prevention (CDC) highlighted that dengue fever cases in the Americas surged to over 4.6 million, with about 4,000 deaths, marking a 13% increase compared to 2022 and a significant rise from previous years. As a result, the increasing incidence of dengue is expected to fuel market growth in dengue treatment.
Key companies in the dengue treatment market are focusing on innovations such as broad-spectrum antiviral drugs to improve treatment efficacy, reduce disease severity, and address multiple serotypes of the dengue virus simultaneously. Broad-spectrum antiviral drugs are medications effective against a wide range of viruses, rather than targeting a specific one. For example, in September 2024, Hyundai Pharmaceutical Co. Ltd., a South Korea-based pharmaceutical company, launched XAFTY, an innovative broad-spectrum antiviral designed to treat multiple viral infections, including COVID-19 and dengue fever. XAFTY features an advanced drug formulation that improves the absorption and effectiveness of niclosamide, has demonstrated safety and efficacy in clinical trials, targets various RNA viruses, and provides versatility against potential future threats, along with the ability for rapid response in regions facing public health emergencies.
In February 2024, Takeda Pharmaceutical Company, a multinational pharmaceutical company based in Japan, collaborated with Biological E. Limited to enhance the production of its dengue vaccine, TAK-003. This partnership aims to increase the annual production of the vaccine to 50 million doses, ensuring sustainable access in dengue-endemic regions and advancing global efforts in dengue prevention. Biological E. Ltd is an India-based biotechnology company specializing in dengue treatment.
Major players in the dengue treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi S.A., Abbott Laboratories, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Incorporated, Emergent BioSolutions Inc., Bharat Biotech International Limited, Inovio Pharmaceuticals Inc., Gennova Biopharmaceuticals Ltd., ABIVAX S.A., Cadila Healthcare Limited, Biological E. Limited
Asia-Pacific was the largest region in the dengue treatment in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dengue treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the dengue treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The dengue treatment market consists of sales of products including antipyretics, hydration solutions, blood products, nutritional supplements, diagnostic kits, and protective measures. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dengue Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dengue treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for dengue treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dengue treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Vaccines; Acetaminophen
2) By Route Of Administration: Parenteral; Oral
3) By Drug Class: Nsaids; Antibiotics; Corticosteroids
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Hospital; Specialty Clinics; Home Healthcare
Subsegments:
1) By Vaccines: Live Attenuated Vaccines; Recombinant Vaccines; Inactivated Vaccines
2) By Acetaminophen: Oral Acetaminophen; Intravenous Acetaminophen
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co Inc.; Sanofi S.A.; Abbott Laboratories
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Dengue Treatment Market Characteristics
3. Dengue Treatment Market Trends And Strategies
4. Dengue Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Dengue Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Dengue Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Dengue Treatment Market Growth Rate Analysis
5.4. Global Dengue Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Dengue Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Dengue Treatment Total Addressable Market (TAM)
6. Dengue Treatment Market Segmentation
6.1. Global Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vaccines
Acetaminophen
6.2. Global Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parenteral
Oral
6.3. Global Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nsaids
Antibiotics
Corticosteroids
6.4. Global Dengue Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Dengue Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Specialty Clinics
Home Healthcare
6.6. Global Dengue Treatment Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated Vaccines
Recombinant Vaccines
Inactivated Vaccines
6.7. Global Dengue Treatment Market, Sub-Segmentation Of Acetaminophen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Acetaminophen
Intravenous Acetaminophen
7. Dengue Treatment Market Regional And Country Analysis
7.1. Global Dengue Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Dengue Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
